[1]
|
Katzberg, R.W. and Lamba, R. (2009) Contrast-Induced Nephropathy after Intravenous Administration: Fact or Fiction? Radiologic Clinics, 47, 789-800. https://doi.org/10.1016/j.rcl.2009.06.002
|
[2]
|
Hou, S.H., Bushinsky, D.A., Wish, J.B., et al. (1983) Hospital-Acquired Renal Insufficiency: A Prospective Study. The American Journal of Medicine, 74, 243-248. https://doi.org/10.1016/0002-9343(83)90618-6
|
[3]
|
Van Der Molen, A.J., Reimer, P., Dekkers, I.A., et al. (2018) Post-Contrast Acute Kidney Injury—Part 1: Definition, Clinical Features, Incidence, Role of Contrast Medium and Risk Factors: Recommendations for Updated ESUR Contrast Medium Safety Committee Guidelines. European Radiology, 28, 2845-2855. https://doi.org/10.1007/s00330-017-5246-5
|
[4]
|
Kellum, J.A. and Lameire, N. (2013) Diagnosis, Evaluation, and Management of Acute Kidney Injury: A KDIGO Summary (Part 1). Critical Care, 17, Article No. 204. https://doi.org/10.1186/cc11454
|
[5]
|
Mehran, R., Aymong, E.D., Nikolsky, E., et al. (2004) A Simple Risk Score for Prediction of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention: Development and Initial Validation. Journal of the American College of Cardiology, 44, 1393-1399. https://doi.org/10.1016/S0735-1097(04)01445-7
|
[6]
|
Abe, M., Morimoto, T., Akao, M., et al. (2014) Relation of Contrast-Induced Nephropathy to Long-Term Mortality after Percutaneous Coronary Intervention. The American Journal of Cardiology, 114, 362-368. https://doi.org/10.1016/j.amjcard.2014.05.009
|
[7]
|
Heyman, S.N., Rosenberger, C., Rosen, S., et al. (2013) Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? BioMed Research International, 2013, Article ID: 123589. https://doi.org/10.1155/2013/123589
|
[8]
|
Wong, P.C., Li, Z., Guo, J., et al. (2012) Pathophysiology of Contrast-Induced Nephropathy. International Journal of Cardiology, 158, 186-192. https://doi.org/10.1016/j.ijcard.2011.06.115
|
[9]
|
Toprak, O., Cirit, M., Yesil, M., et al. (2007) Impact of Diabetic and Pre-Diabetic State on Development of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease. Nephrology Dialysis Transplantation, 22, 819-826. https://doi.org/10.1093/ndt/gfl636
|
[10]
|
Nikolsky, E., Mehran, R., Turcot, D., et al. (2004) Impact of Chronic Kidney Disease on Prognosis of Patients with Diabetes Mellitus Treated with Percutaneous Coronary Intervention. The American Journal of Cardiology, 94, 300-305. https://doi.org/10.1016/j.amjcard.2004.04.023
|
[11]
|
Bansal, S., andPatel, R.N. (2020) Pathophysiology of Contrast-Induced Acute Kidney Injury. Interventional Cardiology Clinics, 9, 293-298. https://doi.org/10.1016/j.iccl.2020.03.001
|
[12]
|
Maioli, M., Toso, A., Gallopin, M., et al. (2010) Preprocedural Score for Risk of Contrast-Induced Nephropathy in Elective Coronary Angiography and Intervention. Journal of Cardiovascular Medicine, 11, 444-449. https://doi.org/10.2459/JCM.0b013e328335227c
|
[13]
|
Scoditti, E., Massaro, M. and Montinari, M.R. (2013) Endothelial Safety of Radiological Contrast Media: Why Being Concerned. Vascular Pharmacology, 58, 48-53. https://doi.org/10.1016/j.vph.2012.10.004
|
[14]
|
Zhang, F., Lu, Z. and Wang, F. (2020) Advances in the Pathogenesis and Prevention of Contrast-Induced Nephropathy. Life Sciences, 259, Article ID: 118379. https://doi.org/10.1016/j.lfs.2020.118379
|
[15]
|
Davidson, C., Stacul, F., McCullough, P.A., et al. (2006) Contrast Medium Use. The American Journal of Cardiology, 98, 42-58. https://doi.org/10.1016/j.amjcard.2006.01.023
|
[16]
|
Hossain, M.A., Costanzo, E., Cosentino, J., et al. (2018) Contrast-Induced Nephropathy: Pathophysiology, Risk Factors, and Prevention. Saudi Journal of Kidney Diseases and Transplantation, 29, 1-9. https://doi.org/10.4103/1319-2442.225199
|
[17]
|
Kane, G.C., Doyle, B.J., Lerman, A., et al. (2008) Ultra-Low Contrast Volumes Reduce Rates of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Coronary Angiography. Journal of the American College of Cardiology, 51, 89-90. https://doi.org/10.1016/j.jacc.2007.09.019
|
[18]
|
Lameire, N., Biesen, W.V. and Vanholder, R. (2008) Acute Kidney Injury. Lancet, 372, 1863-1865. https://doi.org/10.1016/S0140-6736(08)61794-8
|
[19]
|
Urbschat, A., Obermuller, N. and Haferkamp, A. (2011) Biomarkers of Kidney Injury. Biomarkers, 16, S22-S30. https://doi.org/10.3109/1354750X.2011.587129
|
[20]
|
Ferguson, T.W., Komenda, P. and Tangri, N. (2015) Cystatin C as a Biomarker for Estimating Glomerular Filtration Rate. Current Opinion in Nephrology and Hypertension, 24, 295-300. https://doi.org/10.1097/MNH.0000000000000115
|
[21]
|
Wang, M., Zhang, L., Yue, R., et al. (2016) Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography. Medical Science Monitor, 22, 2956-2961. https://doi.org/10.12659/MSM.897241
|
[22]
|
Singer, E., Marko, L., Paragas, N., et al. (2013) Neutrophil Gelatinase-Associated Lipocalin: Pathophysiology and Clinical Applications. Acta Physiologica, 207, 663-672. https://doi.org/10.1111/apha.12054
|
[23]
|
Li, H., Yu, Z., Gan, L., et al. (2018) Serum NGAL and FGF23 May Have Certain Value in Early Diagnosis of CIN. Renal Failure, 40, 547-553. https://doi.org/10.1080/0886022X.2018.1487860
|
[24]
|
Liao, B., Nian, W., Xi, A., et al. (2019) Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN). Medical Science Monitor, 25, 565-570. https://doi.org/10.12659/MSM.912569
|
[25]
|
He, Y., Deng, Y., Zhuang, K., et al. (2020) Predictive Value of Cystatin C and Neutrophil Gelatinase-Associated Lipocalin in Contrast-Induced Nephropathy: A Meta-Analysis. PLOS ONE, 15, e0230934. https://doi.org/10.1371/journal.pone.0230934
|
[26]
|
Li, Q., Huang, Y., Shang, W., et al. (2020) The Predictive Value of Urinary Kidney Injury Molecular 1 for the Diagnosis of Contrast-Induced Acute Kidney Injury after Cardiac Catheterization: A Meta-Analysis. Journal of Interventional Cardiology, 2020, Article ID: 4982987. https://doi.org/10.1155/2020/4982987
|
[27]
|
Akdeniz, D., Celik, H.T., Kazanci, F., et al. (2015) Is Kidney Injury Molecule 1 a Valuable Tool for the Early Diagnosis of Contrast-Induced Nephropathy? Journal of Investigative Medicine, 63, 930-934. https://doi.org/10.1097/JIM.0000000000000243
|
[28]
|
Wybraniec, M.T., Chudek, J., Bozentowicz-Wikarek, M., et al. (2017) Prediction of Contrast-Induced Acute Kidney Injury by Early Post-Procedural Analysis of Urinary Biomarkers and Intra-Renal Doppler Flow Indices in Patients Undergoing Coronary Angiography. Journal of Interventional Cardiology, 30, 465-472. https://doi.org/10.1111/joic.12404
|
[29]
|
Yin, W., Kumar, T., Lai, Z., et al. (2019) Kidney Injury Molecule-1, a Sensitive and Specific Marker for Identifying Acute Proximal Tubular Injury, Can Be Used to Predict Renal Functional Recovery in Native Renal Biopsies. International Urology and Nephrology, 51, 2255-2265. https://doi.org/10.1007/s11255-019-02311-1
|
[30]
|
Yin, C. and Wang, N. (2016) Kidney Injury Molecule-1 in Kidney Disease. Renal Failure, 38, 1567-1573. https://doi.org/10.1080/0886022X.2016.1193816
|
[31]
|
Saliminejad, K., Khorram Khorshid, H.R., Soleymani Fard, S., et al. (2019) An Overview of MicroRNAs: Biology, Functions, Therapeutics, and Analysis Methods. Journal of Cellular Physiology, 234, 5451-5465. https://doi.org/10.1002/jcp.27486
|
[32]
|
Bhaskaran, M. and Mohan, M. (2014) MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease. Veterinary Pathology, 51, 759-774. https://doi.org/10.1177/0300985813502820
|
[33]
|
Sun, S.Q., Zhang, T., Ding, D., et al. (2016) Circulating MicroRNA-188,-30a, and-30e as Early Biomarkers for Contrast-Induced Acute Kidney Injury. Journal of the American Heart Association, 5, e004138. https://doi.org/10.1161/JAHA.116.004138
|
[34]
|
Pistolesi, V., Regolisti, G., Morabito, S., et al. (2018) Contrast Medium Induced Acute Kidney Injury: A Narrative Review. Journal of Nephrology, 31, 797-812. https://doi.org/10.1007/s40620-018-0498-y
|
[35]
|
Nijssen, E.C., Rennenberg, R.J., Nelemans, P.J., et al. (2017) Prophylactic Hydration to Protect Renal Function from Intravascular Iodinated Contrast Material in Patients at High Risk of Contrast-Induced Nephropathy (AMACING): A Prospective, Randomised, Phase 3, Controlled, Open-Label, Non-Inferiority Trial. The Lancet, 389, 1312-1322. https://doi.org/10.1016/S0140-6736(17)30057-0
|